Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

TACGALEN 1 MG/ML EMULSIÓN CUTÁNEA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/TACGALEN 1 MG/ML EMULSIÓN CUTÁNEA

Approved

STANDARD

TACGALEN 1 MG/ML EMULSIÓN CUTÁNEA

Galenicum Derma S.L.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jan 9, 2024
Approval ID: 8910c4995d886cdc
Company: Galenicum Derma S.L.U.
Type: Standard

Approval Details

Approval Id: 8910c4995d886cdc
Drug Cima Aemps Name: TACGALEN 1 MG/ML EMULSIÓN CUTÁNEA
Register Number: 89231
Holder Company Name: Galenicum Derma S.L.U.
Marketing Company Name: Galenicum Derma S.L.
Authorization Date: 2024-01-09
Dosage Form: EMULSIÓN CUTÁNEA
Dose: 1 mg/ml
Route Of Administration: USO CUTÁNEO
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Galenicum Derma S.L.U.

Active Ingredients

TACROLIMUS MONOHIDRATO

1,022 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 9, 2024

Approval ID

8910c4995d886cdc

Type

Standard

Back to CIMA-AEMPS Approvals